Granules Pharmaceuticals, Inc.

About

Granules Pharmaceuticals Inc operates as a leading pharmaceutical manufacturing company based in Manassas, Virginia, serving as the US subsidiary of Granules India. The company operates from a state-of-the-art 100,000 square foot facility that holds both US FDA and DEA approvals, specializing in complex oral solid dosage form manufacturing. The company delivers comprehensive pharmaceutical manufacturing solutions including immediate release tablets and capsules, modified release formulations, delayed and extended-release tablets, orally disintegrating tablets, chewable tablets, and powders for oral solutions. Their advanced microspheres technology enables sophisticated drug delivery systems for challenging pharmaceutical applications. With 34 Abbreviated New Drug Applications filed and 31 approved products, Granules Pharmaceuticals has successfully commercialized 43 pharmaceutical products while maintaining rigorous quality standards. The facility employs over 340 professionals dedicated to producing Trade Agreements Act compliant products that meet stringent regulatory requirements. The company operates under the core principle of delivering Cost, Quality, Continuity and Compliance to pharmaceutical partners. Their integrated approach combines global manufacturing expertise with local US operations, enabling affordable healthcare solutions without compromising quality standards. Through Granules Consumer Health, the company also provides private label over-the-counter product development and manufacturing services. This comprehensive portfolio positions Granules Pharmaceuticals as a trusted partner for pharmaceutical companies seeking reliable, compliant manufacturing solutions in the competitive US pharmaceutical market.